Unacceptable Antibiotic Resistance Rates for Helicobacter pylori in Turkey: Something Must Change.
暂无分享,去创建一个
[1] M. Topbaş,et al. Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. , 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[2] A. Tanoğlu,et al. Helicobacter pylori treatment in Turkey: Current status and rational treatment options , 2019, Northern clinics of Istanbul.
[3] A. Kanık,et al. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies. , 2019, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[4] D. Graham,et al. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. , 2018, Gastroenterology.
[5] A. Zullo,et al. Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010–2016 , 2018, Scandinavian journal of gastroenterology.
[6] A. Babazadeh,et al. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations , 2018, European Journal of Clinical Microbiology & Infectious Diseases.
[7] J. Gisbert,et al. Accuracy of the Ultra-Rapid Urease Test for diagnosis of Helicobacter pylori infection. , 2017, Gastroenterologia y hepatologia.
[8] R. Hunt,et al. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report , 2016, Gut.
[9] G. K. Unler,et al. A Comparison of Five Different Treatment Regimens as the First‐Line Treatment of Helicobacter pylori in Turkey , 2016, Helicobacter.
[10] H. B. Tokman,et al. Prevalence of Primary Antimicrobial Resistance of H. pylori in Turkey: A Systematic Review , 2016, Helicobacter.
[11] Jason Y. Park,et al. Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA , 2016, Digestive Diseases and Sciences.
[12] Deng-Chyang Wu,et al. Diagnosis of Helicobacter pylori infection: Current options and developments. , 2015, World journal of gastroenterology.
[13] F. Ermiş,et al. Current Helicobacter pylori treatment in 2014. , 2015, World journal of methodology.
[14] Y. Erzin,et al. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. , 2015, Revista da Sociedade Brasileira de Medicina Tropical.
[15] T. Ayaz,et al. Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy , 2014, Digestion.
[16] H. Goossens,et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption , 2012, Gut.
[17] G. Lee,et al. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance , 2012, Journal of gastroenterology and hepatology.
[18] Nayoung Kim,et al. Mutations of Helicobacter pylori Associated with Fluoroquinolone Resistance in Korea , 2011, Helicobacter.
[19] Z. Polat,et al. Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia. , 2010, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[20] I. Mitov,et al. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents , 2010, Expert review of anti-infective therapy.
[21] J. Wu,et al. Prevalence of Primary Fluoroquinolone Resistance Among Clinical Isolates of Helicobacter pylori at a University Hospital in Southern Taiwan , 2009, Helicobacter.
[22] U. Akarca,et al. High Helicobacter pylori Resistance Rate to Clarithromycin in Turkey , 2007, Journal of clinical gastroenterology.
[23] T Rokkas,et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report , 2006, Gut.
[24] M. Kist,et al. Quinolone Resistance in Helicobacter pylori Isolates in Germany , 2006, Antimicrobial Agents and Chemotherapy.
[25] Nayoung Kim,et al. Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. , 2006, International journal of antimicrobial agents.
[26] Nayoung Kim,et al. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. , 2005, The Journal of antimicrobial chemotherapy.
[27] C. O'Morain,et al. Helicobacter pylori Infection , 1994 .
[28] M. Osato. Antimicrobial susceptibility testing for Helicobacter pylori: sensitivity test results and their clinical relevance. , 2000, Current pharmaceutical design.
[29] D. Beall. Classification and Grading of Gastritis: The Updated Sydney System , 1997 .
[30] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.